Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of Weekly Paclitaxel in Combination With Cisplatin as Neoadjuvant Therapy for Locally Advanced Breast Cancer Patients

NCT02199418 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT02199418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02199418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of Weekly Paclitaxel in Combination With Cisplatin as Neoadjuvant Therapy for Locally Advanced Breast Cancer Patients
Lead sponsor
RenJi Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
October 31, 2016
Enrollment
132 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory breast cancer, invasive ductal breast cancer, mucinous breast cancer, tubular breast cancer